Best printers for Home

Best Mixer Grinder

Best wired Earphones

Best 43 Inch TV in India

Best Wi Fi Routers

Best Home Theatre in India

Smart Watch under 5000

Best Laptops for Education

Best Laptop for Students

<ul><li>Metropolis is committed to expanding its reach, strengthening its portfolio, and driving sustainable growth.</li><li>Even though Reliance’s Netmeds is offering lower prices, Metropolis has strategically positioned itself to cater to the top end of the market, focusing on high-quality services and specialised tests.</li><li>Company plans to repay ₹40 crore outstanding debt by the end of this fiscal before it goes after new acquisitions. </li></ul> The one sector that did brisk business during the pandemic was diagnostics, as people queued up to get tested for Covid. As the healthcare sector’s capacity came under enormous strain, new players entered the <keyword id="10985234" type="General" weightage="60" keywordseo="diagnostics-sector" source="Orion">diagnostics sector</keyword> to capitalise on the boom, as Indians became more conscious about health and wellness. The stocks of these companies have also rallied between 25-35% in the last six months, even though competitive intensity has sharply risen with new players entering the sector. Business Insider caught up with <keyword id="584350" type="General" weightage="70" keywordseo="ameera-shah" source="Orion">Ameera Shah</keyword> promoter and Managing Director of <keyword id="178996" type="General" weightage="80" keywordseo="Metropolis-Healthcare" source="Orion">Metropolis Healthcare</keyword> along with the company’s CEO <keyword id="15740822" type="General" weightage="40" keywordseo="Surendran-Chemmenkotil" source="Orion">Surendran Chemmenkotil</keyword> to understand if the sector is still in the pink of health after the pandemic. Typically, private equity investments in a sector and increased competitive intensity inevitably leads to a price war, but Shah says Metropolis has strategically positioned itself to cater to the top end of the market, focusing on high-quality services and specialised tests. In a recent interview with BI India, Shah shed light on the impact of competition in the sector and the company's future plans to create more value for customers and investors. Despite all the noise around new age tech players that are doing a lot of bundling of tests at significantly lower prices, Shah says, Metropolis is committed to expanding its reach, strengthening its portfolio, and driving sustainable growth. Impact of Competition in the Diagnostic Sector Competition in the diagnostic sector has been steadily increasing since 2010, with the first private equity investment occurring in 2006. As the industry started to grow, more private equity companies began investing, and numerous new players entered the market. To compete effectively, many local and regional players have resorted to price competition, leveraging lower prices as a means to attract customers. While this has led to a decline in net prices, the distribution margin has increased. Shah emphasises that Metropolis has chosen to focus on the top hospitals, doctors, and corporates as its core customer base, thereby targeting the top end of the market. By providing the best infrastructure, technology, pathologists, and logistics, Metropolis has established itself as a trusted partner for these high-end customers. However, Shah highlighted that talent scarcity was a significant challenge in the sector till recently and attrition rates were high. Furthermore, the entry of tech players during the COVID-19 pandemic, offering home services, temporarily disrupted the market. However, the demand for home services has declined post-pandemic, affecting these tech companies. Shah also mentioned that certain healthcare and non-healthcare companies have set up diagnostic chains, primarily focusing on the lower-margin segment of the market. In contrast, Metropolis remains committed to its high-touch model, prioritising customer needs and human expertise. In its latest quarterly analysis, Kotak Institutional Equities says that the worst of the pricing-led competition in diagnostics is behind the industry, but it is still far from a benign pricing environment. Reliance’s Netmeds has upped the ante in the last few months with pricing now 25-65% lower than Tata 1mg and other national incumbents, respectively. KIE says that after dropping prices in Delhi NCR by 15% in 1QFY24, seemingly on an experimental basis, Metropolis has raised prices in 2QFY24. Its pricing remained largely unchanged in other cities. Metropolis' Future Plans: Metropolis has outlined several strategies to drive growth and maintain its position as a leader in the diagnostic sector. The company aims to increase its reach by opening new labs and service centres, with a target of establishing 90 labs within 30 months. Already having added 30 labs, Metropolis plans to add another 60 in the near future. Additionally, the company plans to expand geographically, both deeper in existing markets and wider in new geographies. Metropolis has 180 labs in all and the company has added 45 ew labs in the last one year and will be adding another 45 labs in the coming months. It has 3700 collection centres every year it plans to add 700 new centres. Explaining the company’s growth plans, Surendran Chemmenkotil says:“We plan to increase reach by opening new labs and service centres. We are strong in the West and South. Expansion geographically is one key strategy to grow. We will go deeper in our existing markets and wider in new geographies. We want to increase wellness revenue in the coming years. Once a consumer takes a wellness package, quite likely they will keep coming back from more, which will help build a sustainable revenue stream.” Recognizing the potential of wellness services, Metropolis aims to increase wellness revenue from the current 14% to 20% in the coming years. By offering comprehensive wellness packages, the company aims to build a sustainable revenue stream, as customers who opt for wellness packages are likely to return for further services. Metropolis also continues to strengthen its portfolio of specialised tests by engaging with specialty doctors and adding new tests, including genetic testing for critical illnesses. Despite the challenges posed by the accelerated rate of expansion, Metropolis remains confident in its financial performance. Explains Shah: “While margins have slightly declined, primarily due to the opening of new labs, the core EBITDA remains unaffected. We plan to repay Rs 40 crore debt we have on our books by the end of this year.” The company is not just content expanding across new and existing markets, it is also on the lookout for <keyword id="30334" type="General" weightage="40" keywordseo="acquisition" source="Orion">acquisition</keyword>s to boost market-share. The company's robust cash flow allows for debt repayment and provides opportunities for potential acquisitions. Says Shah: “We have debt of Rs 40 crore from the acquisition of Hitech Diagnostics, which we will repay by end of fiscal. Our free cash flows after that will be available for potential acquisitions. While large deals are available right now in the market, we will not look at them.” If Metropolis continues to focus on the top end of the market by expanding its portfolio of specialised tests, it will not have to enter into a price war with new age players with deep pockets.

Metropolis on the prowl for acquisitions as sector's competitive intensity eases

<ul><li>Metropolis Healthcare's initial public offering opens on April 3 and closes on April 5.</li><li>The company is a leading diagnostics chain with presence in 197 cities in 19 states.</li><li>HDFC Securities has lined up a set of key risks that may affect investor returns.</li></ul> Metropolis Healthcare is a leading diagnostics chain in India with presence in 197 cities in 19 states across the country. What works in its favour is the headroom for growth in the sector and the locations in which the company is active. The country's diagnostics industry is expected to grow at a compounded rate of 16% in three years starting April 2018 and be worth $12.3 billion by March 2020, according to investment advisors in HDFC Securities said in a report. There are very few Pan-India chains, which together have a share of approximately 35 to 40% of the organized diagnostic market. Regional chains constitute the rest of the market, the report added. 
 
 
 
 
 
 
 <div type="javascript" title="Custom" contenttype="Image"><cdata><![CDATA[
<div class="flourish-embed" data-src="visualisation/276106"></div>
]]></cdata></div>















 While the dearth of branded chains offers an opportunity, regional peers and standalone centres also pose a pricing challenge for companies like Metropolis. 
 <div type="javascript" title="Custom" contenttype="Image"><cdata><![CDATA[
<div class="flourish-embed" data-src="visualisation/276879"></div>
]]></cdata></div>



 Aside from the competition and other business risks-- renewal of licences and approvals, technological advancements, potential government pricing controls, reliance on third party services-- there are other risks pointed out by analysts. Potential legal threats There are several outstanding legal proceedings against Metropolis, subsidiaries, directors and promoters. In particular, the company has sought to compound certain offences under the Companies Act, 2013 before the NCLT and the Registrar of Companies. Further, it has been issued a summon cum show cause notice from the Assistant Provident Fund Commissioner, Employees’ Provident Fund Organisation, Ministry of Labour and Employment, and the government of India. It cannot be assured that these outstanding legal proceedings will be decided in Company’s favor or in favor of its Subsidiaries, Directors or Promoters, or that no further liability will arise out of these proceedings. Further, such legal proceedings could divert management’s time and attention and consume financial resources. A sour joint venture Metropolis Healthcare owns a 34% stake in Star Metropolis, a joint venture in the United Arab Emirates with ETA Star Healthcare. However, the two companies have had certain disagreements since 2011 and Star Metropolis stopped providing any information, including financial information. Further, one of the affiliates of the partner in UAE has been using the ‘Metropolis’ brand to market its pathology services in the Gulf Cooperation Council. This may adversely affect the Indian company and its brand. The trademark is yet to be registered The company has applied for a trademark registration of its logo and name 'Metropolis' and is yet to be approved. There are other risks to intellectual property too. "Infringement claims could also arise in the future as patents could be issued on tests or processes that MHL may be performing, particularly in such emerging areas as gene-based testing and other specialty testing. Any of the foregoing could have an adverse effect on its business, results of operations and financial condition," the report said. The brand is key ingredient to the potential success of the company. Pledged stake Nearly 30% of the stake held by the promoters of the company are to pledged with lenders after the share sale. Promoters may pledge more shares in accordance with terms of the loan after the shares are listed. "Any default under the agreements pursuant to which these Equity Shares would be pledged will entitle the pledgee to enforce the pledge over these Equity Shares," according to the report. A promoter group company is also obliged to inform and take consent of some lenders before carrying out certain activities and entering into certain transactions.

A new IPO in India has its eyes on a $12.3 billion market-- but there are many risks

New Delhi, June 24 () Diagnostic services provider Metropolis Healthcare on Wednesday said that a promoter has divested 6.03 per cent stake in the company for Rs 422.58 crore. The company in an exchange filing said "a member of the promoter group of the company has divested 30,54,545 equity shares of the company constituting 6.03 per cent of the issued and paid-up share capital of the company through a bulk deal transaction on the stock exchanges today". It further said that shares of the company have been sold at a price of Rs 1,383.44 per equity share. The proceeds from this divestment are intended to be used for substantial repayment of the loan availed by Metz Advisory LLP, the company said. "We believe that the reduction of pledge of equity shares by Metz Advisory LLP, Ameera Shah, Sushil Shah and Duru Sushil Shah by substantial repayment of the loan availed by Metz Advisory LLP, is in the overall interests of all the stakeholders," the filing said. "We have sold a small part of our holding today, in line with our commitment to bring down debt and associated pledges at the promoter and promoter group level," Metropolis Healthcare Promoter and MD Ameera Shah said. Shares of Metropolis Healthcare Ltd closed at Rs 1,398.85 per scrip on the BSE, down 3.69 per cent from the previous close. AKT MKJ

Metropolis Healthcare promoter offloads 6.03% stake for Rs 422.58 crore

<keyword id="6587" type="General" weightage="100" keywordseo="karachi" source="Orion">Karachi</keyword> has been named among the worlds worst cities to live in due to poor stability, healthcare, culture, environment and infrastructure. This was determined by the Economist Intelligence Unit in its annual Global Liveability Index 2022, Samaa TV reported. According to the Index, Karachi ranked 168 amongst 173 cities with an index score of 37.5. This placed the Pakistani metropolis squarely in the middle of the bottom 10 cities of the world on the index. It primarily suffered due to poor stability and healthcare. It had a stability score of 20, at par with that of Lagos and Damascus. Its healthcare score was 33.3, which was better than that of <keyword id="6381819" type="General" weightage="50" keywordseo="dhaka" source="Orion">Dhaka</keyword> (29.2) and even Douala, <keyword id="92498" type="General" weightage="50" keywordseo="cameroon" source="Orion">Cameroon</keyword>, both cities which sat several ranks above Karachi, Samaa TV reported. The port city also scored 35.2 for culture and environment above Tripoli but far less than the 40.5 of Dhaka or even 44.9 of Lagos. For education, Karachi had a score of 66.7, far above Dhaka (41.7) and even Tehran (50), both cities which were ranked far higher. In infrastructure, Karachi earned a score of 51.8, a score higher than any of the other cities listed in the bottom 10. Vienna returned to the top of the rankings for the first time since 2019 as the index saw sharp rises following the rollback of Covid-19 restrictions, Samaa TV reported. The top 10 positions were largely dominated by cities in Western European and North American economies. Canada had three cities listed in the top 10 with Calgary the highest-ranked followed by Vancouver and Toronto. Switzerland was the only other country to see multiple cities included in the top 10 ranking with Zurich and Geneva both included. Outside of <keyword id="28249" type="General" weightage="50" keywordseo="europe" source="Orion">Europe</keyword> and <keyword id="6378080" type="General" weightage="50" keywordseo="north-america" source="Orion">North America</keyword>, Osaka and Melbourne managed to break into the top 10, securing ninth and 10th place, respectively. ALSO SEE: <a target="_blank" class="c-link c-message_attachment__title_link" href="https://www.businessinsider.in/international/news/us-senate-passes-1st-gun-control-bill-in-28-yrs/articleshow/92426604.cms">US Senate passes 1st gun control bill in 28 yrs</a> <a target="_blank" class="c-link c-message_attachment__title_link" href="https://www.businessinsider.in/international/news/world-health-network-declares-monkeypox-outbreak-a-pandemic/articleshow/92412273.cms">World Health Network declares monkeypox outbreak a pandemic</a>

Karachi named among world's worst cities due to poor stability, healthcare and culture

Metropolis <keyword id="6354525" type="COMPANY" weightage="60" keywordseo="Healthcare">Healthcare</keyword> is one among the top 3 diagnostic chains in the country. It claims to deliver over 15 million tests a year and to serve over 10,000 Laboratories, Hospitals, Nursing homes and 2,00,000 Consultants. 
 
It’s also the country’s only multinational chain of diagnostic centres with presence in UAE, Sri Lanka, South Africa, Kenya, Mauritius and Ghana. It processes over 4500 varieties of tests and employs over 3500 people. 
 Business Insider sat down with current Managing Director and CEO <keyword id="584350" type="UNKNOWN" weightage="80" keywordseo="Ameera-Shah">Ameera Shah</keyword>, to discuss the Indian <a href="http://www.businessinsider.in/searchresult.cms?query=healthcare+space&amp;sortorder=effectivedate">healthcare space</a> and the future of upcoming <a href="http://www.businessinsider.in/searchresult.cms?query=healthcare+startups&amp;sortorder=effectivedate">healthcare startups</a>. 
 
How’s India similar to other SE Asian markets you’re in? 
All these markets have something in common – <a href="http://www.businessinsider.in/searchresult.cms?query=health+insurance&amp;sortorder=effectivedate">health insurance</a> hasn’t penetrated here in a big way, so people are paying out of their pockets. 
 
That changes the dynamics of the market. Doctors are more careful before prescribing tests, and patients are more careful of the pricing. Here patients become the decision-maker. That’s why convenience is of supreme importance. 
 
We’re seeing double digit growth rate (10-13%) in emerging markets as compared to developed markets in Europe and America which see single digit growth. 
 
Is affordability still the key factor in emerging markets? 
Quality is the number one parameter, affordability comes next. The third one is convenience, and the fourth emerging factor is consumer experience. As education levels rise, people expect a level of hospitality. 
 
Market Size for Diagnostics in India. 
The market is currently $ 5-6 billion, and the top 3 players have managed to get only 10% of the total market. Over time we’ll see that changing. 
 
In the US, 40% of the market is held by the top 3 players, and that’s because of <a href="http://www.businessinsider.in/searchresult.cms?query=health+insurance&amp;sortorder=effectivedate">health insurance</a> penetration. 
 
How do you strike a balance between the latest tech and still make it affordable? 
In the western world people talk about how technology can help reduce cost. In India, manual labor is cheaper. 
 
When it comes to the latest tech, we don’t compromise. However, if something doesn’t affect the quality of the report we choose manual. 
 
Do you see <keyword id="3172082" type="UNKNOWN" weightage="60" keywordseo="healthcare-startups">healthcare startups</keyword> being sucked into the mainstream anytime soon? 
Startups are happening in two main areas – medical devices and mainly IT, with aggregators and the likes. 
 
In medical devices there still hasn’t been a startup that has revolutionized laboratory methods. In the IT space, it’s primarily in the <a href="http://www.businessinsider.in/searchresult.cms?query=preventive+healthcare&amp;sortorder=effectivedate">preventive space</a>. That’s not working in a large way because in healthcare people go with a brand they trust, and they don’t want a new brand that’s coming out of nowhere. There’s some traction because of deep discounting, but how they’ll sustain in the long term is anybody’s guess. 
 
So aggregators may not claim a big part of your business anytime soon? 
Not at all. 
 
The assumption is that once <a href="http://www.businessinsider.in/searchresult.cms?query=Practo&amp;sortorder=effectivedate">Practo</a> and the likes make inroads into doctors’ clinics, they can tell the doctor where to send the patient for diagnostics. However, these are <a href="http://www.businessinsider.in/searchresult.cms?query=IT+software&amp;sortorder=effectivedate">IT software</a> companies, but the Doctor will send a patient to a hospital based on his medical knowledge. 
 
What happens with services like these is that patients search for doctors like a directory of services. However, there’s no quality listing. 
 
Patients still go by word of mouth versus a recommendation by an IT app. 
 
Unless the quality listing comes into play, its difficult, and that raises a 2nd question – how will they determine what is a good doctor from a bad one. Doctors/Diagnostic chains can’t be rated by stars or quantifiable parameters. 
 
How they’ll make these lists is a little bit of a question mark. 
 
What kind of a startup can help you take a leap into the next stage of your expansion? 
At this point, I don’t see a model. Rather, we can help startups. 
 
They are absolutely new in healthcare, and they don’t have either the track record, or the brand value that doctors trust. There is an asymmetry in consumer education in India. 
 
More work on consumer education might be helpful for brands like us. 
 
Do you see the word-of-mouth recommendation model changing anytime soon for healthcare? 
There are no alternatives. 
 
You rather believe a distant niece, nephew or cousin who’s been to the clinic rather than a random website where you don’t know how they’ve done the listing. You’re going to believe a website basis what! 
 
People don’t want to take chances with their health. That’s the biggest barrier for any new player, and also what protects the industry. 
 
Any plans for an IPO? 
I don’t see anything in the next 6 months. 
 
Our industry is seeing great valuations in the public market, and as a company which has built a presence, it’s a very good opportunity for us if we do decide to go public.

Exclusive: ‘You’re going to believe a website
basis what!’ : In conversation with Metropolis MD-CEO
Ameera Shah

Just when India was recovering from the bitter taste of <keyword id="2894644" type="UNKNOWN" weightage="100" keywordseo="MaggieinSoup">#Maggieinsoup</keyword>, Indians got another health risk warning. Days after lead was found in instant food Maggi, an analysis, done by <keyword id="178996" type="COMPANY" weightage="60" keywordseo="Metropolis-Healthcare">Metropolis Healthcare</keyword>, of blood samples collected over a period of one year from across the country has revealed that over 23 per cent of the total samples tested positive with <keyword id="520366" type="UNKNOWN" weightage="80" keywordseo="lead-poisoning">lead poisoning</keyword>. 
 
 "A pan-India analysis of 733 blood samples collected over last one year has revealed that 23.47 per cent (172 samples) of the total samples tested positive with Lead poisoning," Dr Sandeep Warghade, Consulting Pathologist Metropolis Healthcare told PTI. He added that lead poisoning can be hard to detect and even people <keyword id="6366244" type="ORGANIZATION" weightage="80" keywordseo="WHO">who</keyword> look healthy can have high levels of lead. 
 
 
"At high levels of exposure, lead damages the brain and central nervous system and can lead to coma, convulsions and even death. Signs and symptoms of lead poisoning usually don't appear until dangerous amounts have accumulated," Warghade added. 
 
 
According to a WHO study, lead exposure is estimated to account for 1,43,000 deaths per year with the highest burden in developing regions. 
Lead poisoning is a cumulative toxicant, particularly harmful to young children and can affect multiple body systems, he said. Major sources of blood lead include leaded contaminated soil, drinking water, petrol emissions, household dust, battery recycling, silver refining, paints (especially yellow), pigments, printing presses, ceramic pottery glazes, cosmetics, colours (including vermilion, spices, Holi colours), crayons and painted pencils, plant foods. In growing children, it causes low IQ, hyperactivity, attention deficit, learning disabilities and anaemia, he said. 
 
 
Warghade cautioned that lead poisoning cases in young children are high as they tend to lick or eat lead-containing paint when it peels off the walls or while playing with toys. 
 
 
Lead from a mother's blood can pass to the foetus during pregnancy, possibly giving rise to genetic disorders. 
 
 
"Exposure of pregnant women to high levels of lead can cause miscarriage, stillbirth, premature birth and low birth weight, as well as minor malformations. Women with high blood lead levels develop early osteoporosis, lower backache, joint pain and persistent anaemia," he said. 
 
 
(image credits: hgreatermalaysia.com)

More bad news for Maggi? 23% blood samples tested positive for lead poisoning

<ul><li><keyword id="1979075" type="COMPANY" weightage="20" keywordseo="INDEGENE">Indegene</keyword> is a 23-year-old healthtech solutions provider with interests across pharmaceuticals, biotechnology solutions, and medical devices.</li><li>Both the firms will pick up minority stakes in Indegene, through a primary as well as secondary transaction.</li><li>According to reports, Indegene’s valuation has jumped to $700 million.</li></ul>American private equity giant The <keyword id="44803" type="CITY" weightage="20" keywordseo="Carlyle-group">Carlyle Group</keyword> and investment firm <keyword id="10696504" type="UNKNOWN" weightage="20" keywordseo="brighton-park">Brighton Park</keyword> have pumped in $200 million into Indian healthtech firm Indegene. Both the firms will pick up minority stakes in Indegene, through a primary as well as secondary transaction by buying out existing investors. According to <a href="https://www.business-standard.com/article/companies/indegene-s-valuation-reaches-700-mn-raises-200-mn-from-carlyle-brighton-121020300051_1.html#:~:text=According%20to%20the%20sources%2C%20the,increased%20to%20about%20%24700%20million.">reports</a>, Indegene’s valuation has jumped to $700 million after the deal. Indegene is a 23-year old is a healthtech solutions provider with interests across pharmaceuticals, biotechnology solutions, and medical devices. The company has over 3,000 employees in offices across India, North America, Europe, China and Japan. With the latest investment, the company now aims to expand its global presence and M&amp;A activities. “Carlyle’s commitment to the <keyword id="6354525" type="UNKNOWN" weightage="20" keywordseo="healthcare">healthcare</keyword> sector with their global network and deep pharmaceutical expertise, coupled with Brighton Park’s deep experience in the technology sector and nuanced understanding of our space, makes the two firms the ideal partners to support our company’s continued growth,” said Manish Gupta, co-founder and CEO of Indegene. The company also claims that its revenues grew at around 25% every year for the last ten years. Meanwhile, Carlyle has been ramping up its India presence especially in the health sector. The firm invested in Piramal Pharma; a pure-play animal healthcare company SeQuent; Delhi Medanta Medicity Hospital, and diagnostic center and laboratory operator Metropolis Healthcare. It has also invested in startup unicorns like Delhivery. One of Carlyle’s senior advisors is Aditya Puri, the former HDFC Bank CEO, who has recently joined the PE firm.

Carlyle, Brighton Park invest $200 million in Indian healthtech company Indegene

<ul class="summary-list"><li>Saudi Arabia's planned megacity, Neom, is billed as a chance to live in the "new future."</li><li>Officials want to fill 262 vacancies. The unusual roles show what it will take to run the city.</li></ul>Saudi Arabia is pushing ahead with its ambitious plans for Neom, a futuristic metropolis spread across 26,500 km² in the northwestern region of Tabuk.First announced in 2017, Neom is the flagship project of <a target="_blank" href="https://www.businessinsider.com/saudi-arabia-crown-prince-mohammed-bin-salman-mbs-2023-10">Crown Prince Mohammed bin Salman's</a> Vision 2030 — an initiative to diversify Saudi Arabia's economy and reduce its reliance on oil revenues.There have been <a target="_blank" href="https://www.businessinsider.com/saudi-arabia-neom-the-line-cost-vision-2030-projects-2024-4">reports of setbacks</a>, but <a target="_blank" href="https://www.businessinsider.com/saudi-arabia-neom-megaproject-not-struggling-vision-2030-minister-2024-4">officials previously said</a> the project was on track. If construction does goes to plan, Neom will include Oxagon, an octagonal port city; Sindalah, a luxury island resort; Trojena, a ski and adventure resort; and a tourism hub in the Gulf of Aqaba.But the <a target="_blank" href="https://www.businessinsider.com/neom-saudi-arabia-desert-megacity-plans-look-pictures-2024-4">centerpiece of Neom</a> is The Line — a planned zero-carbon city featuring two huge mirrored skyscrapers that extend 170 km across Tabuk.Officials say Neom will be a "cognitive city." The idea is similar to a smart city, but expands on the concept. In this case, the idea is to use tech such as AI and robotics to provide an optimum experience for residents.<div type="image" title="Neom construction." height="1125" width="2436" msid="110059167" hostid="261"></div>But once — or if — Neom is finally up and running, it will require a whole slate of unusual jobs to fulfill its vision as a revolutionary city.Recruitment is already underway."Join us on a journey of visionary minds where you seek to understand, embrace culture, make a difference, and create a legacy," the project's jobs board invites prospective candidates.There were <a target="_blank" href="https://careers.neom.com/careers">262 vacancies</a> on Neom's website at the time of writing. Some would be common in any city planning project: construction manager, engineer, digital marketing web ops, and, maybe at a stretch, golf course design manager.Other roles required to run Neom suggest just how futuristic, and perhaps a little dystopian, the city could be.<h3 id="ad1895dc-a162-45ad-a577-a88f8b104887">Tech services and system manager</h3>Though it sounds like a standard tech job, this role is a managerial position for the Neom Community School. Candidates for Arabic and Islamic teachers, music teachers, and an "individuals and societies teacher" are also wanted for the city's wide-ranging education system.The school is part of the wider <a target="_blank" href="https://www.neom.com/en-us/our-business/sectors/education-research-and-innovation">Neom U</a> project, a vast education arm that appears to be crucial to the city's vision as a hub of research and innovation.Neom is also searching for someone to fill a <a target="_blank" href="https://careers.neom.com/careers/job?domain=neom.com&amp;pid=563087399700686&amp;query=head%20of%20student%20attraction&amp;domain=neom.com&amp;sort_by=relevance&amp;triggerGoButton=false&amp;job_index=0">head of student attraction</a> role.Job responsibilities include "ensuring that Neom is considered to be the most attractive place to live and work" and preparing the "brightest young minds" for careers within Neom.<h3 id="65973ad6-bcf4-42c7-b923-d85440b0a957">Director of personalized health</h3><a target="_blank" href="https://www.neom.com/en-us/our-business/sectors/health-wellbeing-and-biotech">Officials said </a>The Line aims to prioritize its citizens' health and well-being over transportation and infrastructure, and it will "harness innovative technology" to do so.The personalized health director is expected to play a crucial role in delivering those promises by "steering and defining Neom's strategy for integrating genetics into personalized healthcare."The <a target="_blank" href="https://careers.neom.com/careers/job?domain=neom.com&amp;pid=563087399895824&amp;query=Director%20of%20Personalized%20Health%20&amp;domain=neom.com&amp;sort_by=relevance&amp;triggerGoButton=false&amp;job_index=0">job description</a> says genetic data will be used to pinpoint health risks and develop health interventions.It's unclear whether providing your genetic data will be a requirement for living in Neom. However, some experts have raised <a target="_blank" rel="" href="https://www.businessinsider.com/saudi-crown-princes-china-deals-hint-city-darker-neom-mbs-2023-3">ethical issues about the plans</a>, warning that Neom could become part of a sweeping surveillance program.<h3 id="fbc5f989-0295-4835-bfb1-13f3a7b7ec06">Water mobility station professional</h3>Advanced, zero-emission transport systems are core to Neom's strategy; and the project's waterside estates, Oxagon and Sindalah, are planned to be equally futuristic.The water mobility station professional is a role on offer for those willing to oversee the smooth running of Neom's "water mobility station," or in other words, boat services.While this job doesn't seem to differ that much from traditional marina management, you'll need to speak fluent Arabic and English and be prepared to handle autonomous, futuristic vessels.<div type="image" title="Sindalah, Neom" height="1080" width="1920" msid="110059169" hostid="261"></div><h3 id="79167c5b-25fd-473c-88ad-feb703cb7f2a">Aquaculture fish laboratory and biosecurity professional</h3>Not a job that most cities deem to be a requirement, the aquaculture fish laboratory and biosecurity professional was one of the more unexpected roles on offer at Neom.The <a target="_blank" href="https://careers.neom.com/careers/job?domain=neom.com&amp;pid=563087399774804&amp;query=Aquaculture%20Fish%20Laboratory%20and%20Biosecurity%20Professional&amp;domain=neom.com&amp;sort_by=relevance&amp;triggerGoButton=false&amp;job_index=0">chosen candidate</a> will control and operate the fish laboratory, ensuring high standards of fish welfare and supporting surveillance and investigation activities into fish health and disease control.The role falls in line with Neom's <a target="_blank" href="https://www.vision2030.gov.sa/en/projects/neom/">sustainability ambitions,</a> where humanity progresses without damaging the health of the planet.Plus, a thriving fish population would also support diving tourism. Developers have said they want the island resort Sindalah to act as an "exclusive gateway to the stunning Red Sea."<h3 id="0235e798-d06a-4e21-90e2-dc5d4b8a37d1">Lead rewilding</h3>Another job that highlights Neom's supposed ecological considerations is <a target="_blank" href="https://careers.neom.com/careers/job?domain=neom.com&amp;pid=563087399923098&amp;query=Lead%20rewilding&amp;domain=neom.com&amp;sort_by=relevance&amp;triggerGoButton=false&amp;job_index=0">lead rewilding</a>.This job requires someone willing to get involved in Neom's "trophic rewilding strategy." They will help build wildlife corridors, monitor species, and conduct vegetation assessments in order to "address historical degradation that left the land in a desolated state."<div type="image" title="Neom" height="9504" width="6336" msid="110059170" hostid="261"></div>Perhaps the best job offered at Neom, the lead rewilding hire will develop and implement a cheetah introduction and management plan.Those with a degree in conservation, ecology, natural sciences, or a related field can step forward.Despite Neom's proclaimed efforts towards environmental protection, some have criticized the treatment of people who have reportedly been driven from the construction site.In May 2023, it was reported that three men from the Howeitat tribe were charged with terrorism and <a target="_blank" href="https://www.ohchr.org/en/press-releases/2023/05/saudi-arabia-un-experts-alarmed-imminent-executions-linked-neom-project#:~:text=Mr%20Shadly%20Ahmad%20Mahmoud%20Abou,Appeal%20on%2023%20January%202023.">sentenced to death</a> for resisting evictions in the area where Neom is being developed.Neom officials did not immediately respond to Business Insider's request for comment.

Saudi Arabia's Neom is looking to fill 262 job vacancies. The roles show just how futuristic the megacity could be.

<ul class="summary-list"><li>Topeka, Kansas, is an emerging hotspot for movers seeking cheaper homes and a robust job market.</li><li>A typical home in Topeka costs $149,000, nearly half as much as in nearby Kansas City.</li></ul>Adam Outlaw <a target="_blank" href="https://www.businessinsider.com/choose-topeka-kansas-professionals-why-moved-boston-san-diego-2021-3">moved from Boston to Topeka, Kansas, in 2021</a> and planned to stay there a while.Outlaw left the busy northeast metropolis after being swayed by <a target="_blank" href="https://choosetopeka.com/choose-topeka/">Choose Topeka</a>, a program that incentivizes people to move to the 125,000-person town by offering up to $15,000 to homebuyers or up to $10,000 to renters in the first year.While the moving cash was a perk, the millennial was really drawn by the work opportunities and low cost of living. Outlaw, a renter, said the $10,000 went a lot farther in Topeka as he was able to shed the four roommates he had in Boston and gain "considerably" more square footage — all while saving 75% on rent."Being able to move around freely and park in a driveway is something I do not take for granted anymore," he said.Outlaw is one of many movers who have taken to the Kansas capital's shine. Topeka, about an hour drive west of Kansas City, was dubbed the <a target="_blank" href="https://www.realtor.com/research/october-2023-wsj-rdc-emerging-housing-markets-index/">top emerging housing market</a> in fall 2023 by Realtor.com, owing in part to its low cost of housing and the number of homes available on the market. It's traits like these, as well as Topeka's many manufacturing jobs and warehouse at household-name companies, that are <a target="_blank" href="https://www.businessinsider.com/genz-moving-10-states-midwest-mountains-dakotas-idaho-iowa-utah-2023-10#6-wisconsin-5">winning Gen Zers</a>, investors, and budget-conscious movers to the small city.<h2>Homes are cheaper here</h2>While nearby cities like Kansas City and Overland Park have <a target="_blank" href="https://www.businessinsider.com/taylor-swift-travis-kelce-boost-kansas-city-golden-era-2023-12">grabbed headlines</a> and movers with their <a target="_blank" href="https://www.businessinsider.com/moving-to-kansas-from-brooklyn-climate-crisis-housing-affordability-2023-5">affordability</a> and <a target="_blank" href="https://www.businessinsider.com/best-places-to-buy-a-home-united-states-affordable-2023-3#2-overland-park-kansas-14">diversity</a>, Topeka has flown under the radar. But that's a boon to it now, Realtor.com said, as the median home prices in those nearby cities continue to grow and price people out. The median home price in Kansas City, only an hour from Topeka, is $271,500. According to real-estate company Redfin, the median sales price for a home in Topeka was $90,800 in March 2019. As of November, it's $149,000 — a 64% increase, but still far less than the national median home price of $408,732. <div type="image" title="A residential neighborhood near Topeka, Kansas's downtown." height="1298" width="2310" msid="106330876" hostid="261" sizebytes="548610"></div>Greg Pert, a real-estate agent with Keller Williams based in Topeka, said the upward trend is noticeable."I'd say there was a flat line of 20 years where there was just very, very little increase in value," Pert said. "It's almost as though it finally caught up."Between March 2019 and November, the median number of days a house spent on the market decreased from 61 to 11. Pert said that while the market is hotter than it once was, it has chilled a bit from its peak frenzy."There were times this year where there was less than a week's worth of inventory," Pert told BI. "Six months to two and a half years ago, it was just rampant — there was no inventory. Things were getting five to 10 bids on a single property."Because Topeka is so up-and-coming, it's also a target for out-of-towners looking to invest in real estate. According to Pert, movers are coming from all over the country, and investors are also taking advantage."I've got clients from California to Pennsylvania and in between that love this market because it's such a high amount of rents and it's relatively cheap to buy compared to most of their own local markets," he said. "And so it's a really good rate of return to have a rental portfolio here in Topeka."<h2>Lots of jobs and a growing scene</h2>It's easy to get on a highway and drive to another place for work or leisure from Topeka, but the city has its own perks: namely lots of jobs for household-name companies. <div type="image" title="A Walmart 18-wheeler on a highway." height="3656" width="5481" msid="106330877" hostid="261" sizebytes="1717374"></div>"We have the Mars candy-bar factory, we have a Frito-Lay chip-making factory, we have Goodyear Tires manufacturing tires over there," Sara Hogelin, a real-estate agent with Liberty Real Estate, told BI. "We just have a lot of industry."The state's largest Walmart distribution center is there, as is Hill's Pet Nutrition. Realtor.com also noted that, as the state capital, Topeka boasts government and healthcare jobs, too.It all adds up to a low unemployment rate, at 2.9%, according to Realtor.com. The national unemployment rate hovers around 3.7%.As the city flourishes, so too do its perks. "There is a decent art scene in Topeka and the variety of restaurants is growing," wrote a Reddit commenter. "Also, there are more coffee shops than I would expect from a small city." Hogelin said that while Topeka doesn't have "big wow factors," it's trying to level up. "They're trying to redo the downtown area, they revamped the capitol. They're trying to bring life back to areas that had gotten pretty depressed," she said. "It's an affordable place for living, and there are some really good school districts as well."

Cities to watch in 2024: People move to Topeka, Kansas, for cheaper homes and more jobs

As the world continues to evolve and adapt, so too does the way we <keyword id="6355058" type="General" weightage="20" keywordseo="work" source="Orion">work</keyword>. <keyword id="824043" type="General" weightage="20" keywordseo="business-insider" source="Orion">Business Insider</keyword> India is back with its second edition of The <keyword id="1967222" type="General" weightage="20" keywordseo="future-of-work" source="Orion">Future of Work</keyword> Summit 2023 in Mumbai this Friday, March 17. The conclave aims to explore the latest trends and advancements in the way we work. This year's agenda is focused on several key areas that are transforming the world of work as we know it: technology, cultural intelligence, upskilling and human capital. Let’s get onto what you can expect at the FoW Summit 2023. The future of <keyword id="11018" type="General" weightage="20" keywordseo="jobs" source="Orion">jobs</keyword> is tied in with the technology revolution, upskilling and the ability to find the confluence between work, technology and human experience. The day begins with a keynote address by Maharashtra’s Labour Secretary, Vinita Vaid Singal on the impact of technology on workforce, the need for reskilling and upskilling programmes to ensure that workers are equipped with skill sets to thrive in a changing job market. <h5 style="line-height:1.2;background-color:#ffffff;margin-top:12pt;margin-bottom:12pt;">Final call to <a href="http://businessinsider.in/fow2023">register </a>and be a part of all the action</h5>The rest of the sessions are broadly categorised into four sections - <ul><li>Enhancing Human Capital: The need for policies to align employee growth and business strategies to ensure that both workforce and business can thrive. -Nitin Sethi, CEO, Aon Consulting, India &amp; South Asia -Naiyya Saggi, Co-Founder, Good Glamm Group -Karan Virwani, CEO, WeWorkIndia </li><li>Technology: The future of work and technology and the tools driving digital transformation across workplaces over the next decade -Ashok Krish, Global Lead - Digital Workplace, TCS -Sumedha Chakraborty, Country Head, India &amp; SAARC Business, Google Workspace, Google Cloud -Mukesh Jain - CTO, VP &amp; Global Head of Innovation with AI/ML, Insights &amp; Data - Capgemini </li><li>Upskilling and push for Diversity, Equity, Inclusion (DEI): Two cornerstones that HR leaders must focus on to create a productive, diverse workforce that can adapt to changing needs of business. -C Jayakumar, Executive VP &amp; <keyword id="6378374" type="General" weightage="20" keywordseo="chro" source="Orion">CHRO</keyword>, Larsen &amp; Toubro -Harshvendra Soin, Global Chief People Officer and Head Marketing, Tech Mahindra -Ryan Lowe, Partner - People Advisory Services, E&amp;Y -Harish Iyer, Head - DEI, Axis Bank -Ishita Medhekar, CHRO, Metropolis Healthcare -Neha Bagaria, Founder &amp; CEO, JobsForHer </li><li>Culture, Content &amp; Creator Economy that focuses on the future of storytelling in India: How new platforms are revolutionizing the way we consume and tell stories and the opportunities it presents for content creators. -Rohan Joshi, Influencer, Comedian, Co-Founder - All India Bakchod -Advait Gupt, Co-Founder &amp; CEO, Kulfi Collective -Varun Duggirala - Influencer, Podcaster, Entrepreneur -Karishma Mehta, Founder &amp; CEO, Humans of Bombay</li></ul>Co-powered by Google Cloud, the Future of Work Summit 2023 is a confluence of the brightest minds reimagining the new era of work, workplace and workforce. Discover new trends shaping the workplace and learn about the strategies and tools that can help you stay ahead of the curve. Register <a href="http://businessinsider.in/fow2023">now</a>!

Final countdown begins! Here’s your guide to the Future of Work Summit 2023

<ul><li>India’s Chief <keyword id="193571" type="POSITION" weightage="20" keywordseo="economic-advisor">Economic Advisor</keyword> KV Subramanian claims that private sector healthcare is not much better than public sector healthcare even though it is much more expensive.</li><li>Coming a couple of days before the budget, this may be a shock for the likes of hospital chain operators like Apollo Hospitals, Fortis Health and Metropolis.</li><li>To address the information asymmetry in the healthcare system, the Economic Survey proposes setting up a central database for patient information and a regulator to oversee all stakeholders.</li></ul>Private sector healthcare in India is considered to be superior to the public sector because it’s more expensive and the quality is better. However, the latest economic survey points out that may not necessarily be the case. Therefore, India’s Chief Economic Advisor (CEA), KV Subramanian, has recommended the government must seriously consider a regulator for both <keyword id="10673739" type="UNKNOWN" weightage="20" keywordseo="private-hospitals-and-doctors">private hospitals and doctors</keyword>. Coming a couple of days before the budget, this may be a shock for the likes of hospital chain operators like Apollo Hospitals, Fortis Health and Metropolis. <table style="border-width: initial; border-style: none; width: 468pt; table-layout: fixed;"></colgroup><tbody><tr><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">Company </td><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">Percentage change in stock price </td></tr><tr><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">Apollo Hospital </td><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">-2.14% </td></tr><tr><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">Fortis Health </td><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">-0.62% </td></tr><tr><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">Metropolis </td><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">-1.06% </td></tr></tbody></table>Source: NSE closing prices on January 29 Data shown by the CEA to back his argument The rate of readmission — going back to a hospital for care after original admission — is higher in the <keyword id="6371888" type="UNKNOWN" weightage="20" keywordseo="private-hospitals">private hospitals</keyword> and healthcare facilities than in the public sector. This is based on data collected from the government-funded health programme, Prime Minister’s Jan Arogya Yojana (PMJAY) — also called the Ayushman Bharat Yojana. <table style="border-width: initial; border-style: none; width: 468pt; table-layout: fixed;"></colgroup><tbody><tr><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">Private sector admission rate </td><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">Public sector readmission rate </td></tr><tr><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">70% </td><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">64% </td></tr></tbody></table> According to the CEA, this is worrying not only because the private sector is more expensive, but also because readmissions tend to pinch the pocket more than original admissions and original. <table style="border-width: initial; border-style: none; width: 468pt; table-layout: fixed;"></colgroup><tbody><tr><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">Metric </td><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">Original admission </td><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">Readmission </td></tr><tr><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">Average claim amount </td><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">₹12,652 </td><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">₹19,295 </td></tr><tr><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">Average length of stay </td><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">6.6 days </td><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">7.5 days </td></tr></tbody></table> “So, a large proportion of deaths in India manifesting due to poor quality of healthcare is likely to reflect that the quality of treatment in the private sector may not be significantly better than that in the public sector in India,” said the Economic Survey. <div type="image" title="snapshot-1611921714260" msid="80585582" hostid="261" caption="&amp;lt;p&amp;gt;Variation in costs between private and public healthcare sector&amp;lt;/p&amp;gt;"></div> The government now plans to increase public healthcare spend to 2.5% of GDP to reduce the out of pocket spend from 65% to 35%. “Given the market failure due to asymmetric information, regulation in the healthcare sector is required,” said Subramanian, during the press conference. The CEA proposes this asymmetry can be mitigated using information from within the National Digital Health Mission, even within the framework of data privacy. “A standardised system for quality reporting on healthcare for hospitals, physicians, and insurance companies can start with basic input indicators to be reported mandatorily by healthcare stakeholders,” said the Survey. <div type="javascript" title="Custom" contenttype="Video"><cdata><![CDATA[]]></cdata></div> SEE ALSO: <a href="https://www.businessinsider.in/budget/news/highlights-from-indias-annual-economic-survey-ahead-of-budget-2021/slidelist/80574947.cms">Highlights from India’s annual economic survey ahead of budget 2021</a> <a href="https://www.businessinsider.in/policy/economy/news/latest-economic-survey-has-an-entire-chapter-on-sp-fitch-and-moodys-being-biased-against-the-indian-market-/articleshow/80579836.cms">India’s Chief Economic Advisor trains his guns on global rating agencies</a> <a href="https://www.businessinsider.in/india/news/mumbai-local-trains-will-be-open-to-public-from-february-1-divides-service-into-three-time-slots/articleshow/80573902.cms">Maharashtra opens up Mumbai local trains for public from February 1 — divides service into three time slots</a>

India needs a regulator for private hospitals and doctors, says Chief Economic Advisor

<ul><li><keyword id="12496770" type="General" weightage="20" keywordseo="tarsons-products-ipo" source="Orion">Tarsons Products IPO</keyword> is all set to list in stock exchanges tomorrow, November 26.</li><li>Investors have shown good interest in the IPO as it has been subscribed 77.49 times.</li><li>The grey market premium of the Indian labware company has come down to ₹170 from ₹200 earlier.</li></ul>Indian labware company Tarsons Products is all set to list its initial public offering (IPO) on stock exchanges tomorrow, November 26. The IPO has shown a good response from investors as it has been subscribed 77.49 times. While the company was looking to raise ₹1,024 crore through the IPO, it received bids for ₹55,625 crore. Investors have bid for 84 crore stocks out of 1.08 stock available for bids. <table style="border-width: initial; border-style: none; table-layout: fixed; width: 468pt;"></colgroup><tbody><tr><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">Investors </td><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">Subscription status </td></tr><tr><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">Qualified Institutional Investors </td><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">115.77 times </td></tr><tr><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">Non-Institutional Investors </td><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">184.58 times </td></tr><tr><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">Retail </td><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">10.56 times </td></tr><tr><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">Overall </td><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">77.49 times </td></tr></tbody></table> However, the grey market premium of the Indian labware company has come down to ₹170 from ₹200 earlier. The IPO consisted of a fresh issue of equity shares worth ₹150 crore and an offer for sale (OFS) of 1.32 crore equity shares that will be sold by promoters and an investor. Some of the company’s clients include Dr Reddy's Laboratories, Metropolis Healthcare, Dr. Lal Path Labs. Tarsons sells nearly one in every ten labware products sold in India. Analysts are betting big on the healthcare sector even post covid and expect the labware products company to continue growing. “COVID has turned out to be a boon for the companies in the healthcare space as worldwide governments have started allocating more funds and people in general have become more conscious towards the healthcare benefits. We expect the firm to grow faster than current CAGR [compound annual growth rate] given the laboratory instrument industry is growing at 20%,” said analysts at Nirmal Bang. Tarsons Products is engaged in designing, developing, manufacturing and supplying a diverse range of quality labware products used in laboratories across research organisations, academic institutes, pharmaceutical firms, diagnostics companies and hospitals. SEE ALSO: <a target="_blank" class="c-link c-message_attachment__title_link" href="https://www.businessinsider.in/stock-market/news/how-to-check-go-fashions-ipo-allotment-status/articleshow/87891055.cms">Go Fashion IPO’s allotment status would be announced today, GMP at ₹425</a> <a target="_blank" class="c-link c-message_attachment__title_link" href="https://www.businessinsider.in/stock-market/news/reliance-industries-coal-india-and-other-top-stocks-to-watch-out-for-on-november-25/slidelist/87901109.cms">Reliance Industries, Coal India and other top stocks to watch out for on November 25</a>

You Searched For "Metropolis Healthcare" and got 12 results

Metropolis on the prowl for acquisitions as sector's competitive intensity eases

Malini Bhupta

A new IPO in India has its eyes on a $12.3 billion market-- but there are many risks

Sriram Iyer

Metropolis Healthcare promoter offloads 6.03% stake for Rs 422.58 crore

PTI

Karachi named among world's worst cities due to poor stability, healthcare and culture

IANS

Exclusive: ‘You’re going to believe a website basis what!’ : In conversation with Metropolis MD-CEO Ameera Shah

Saikat Pyne

More bad news for Maggi? 23% blood samples tested positive for lead poisoning

BI India Bureau

Carlyle, Brighton Park invest $200 million in Indian healthtech company Indegene

Sanchita Dash

Saudi Arabia's Neom is looking to fill 262 job vacancies. The roles show just how futuristic the megacity could be.

Polly Thompson

Cities to watch in 2024: People move to Topeka, Kansas, for cheaper homes and more jobs

Jordan Pandy

Final countdown begins! Here’s your guide to the Future of Work Summit 2023

BI India Bureau

India needs a regulator for private hospitals and doctors, says Chief Economic Advisor

Prabhjote Gill

Tarsons Products IPO listing tomorrow; GMP staggers around ₹170

Bhakti Makwana

Popular Keywords

Buying Guides